Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Menopause causes dry skin, wrinkles, and hair changes, with hormone therapy helping but not recommended just for these issues.

Menopause can cause hair thinning and texture changes due to hormonal and metabolic shifts.

Lovastatin doesn't improve lower urinary tract symptoms treatment.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Early hair loss may indicate prostate issues.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Early diagnosis and treatment of PCOS in teenagers can help prevent more severe adult PCOS.

Finasteride may not affect gynecomastia recurrence after mastectomy.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Early hormones shape sex-specific differences in rat glands.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.